{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:03:07Z","timestamp":1787839387219,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ygyno.2017.04.009","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T13:46:10Z","timestamp":1494251170000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes"],"prefix":"10.1016","volume":"146","author":[{"given":"Melissa K.","family":"Frey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Sobolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Y.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Sapra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Pothuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie V.","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.04.009_bb0005","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","article-title":"Linkage of early-onset familial breast cancer to chromosome 17q21","volume":"250","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamaoncol.2015.2699","article-title":"Usefulness of multigene testing: catching the train that's left the station","volume":"1","author":"Swisher","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/1389202916666150317232930","article-title":"Management of incidental findings in the era of next-generation sequencing","volume":"16","author":"Blackburn","year":"2015","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0030","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","article-title":"Limited family structure and BRCA gene mutation status in single cases of breast cancer","volume":"297","author":"Weitzel","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0035","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2015.08.006","article-title":"Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening","volume":"139","author":"Frey","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0045","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2012.01.014","article-title":"The genetic basis for cancer treatment decisions","volume":"148","author":"Dancey","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0065","series-title":"Breast and Ovarian (Version 1.2016)","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Genetic\/Familial High-Risk Assessment","year":"2016"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0070","series-title":"Colorectal (Version 1.2016)","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Genetic\/Familial High-Risk Assessment","year":"2016"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0075","series-title":"Breast and Ovarian Version 2.2017","author":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Genetic\/Familial High-Risk Assessment","year":"2016"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0080","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1016\/j.ejca.2013.06.040","article-title":"The APC p.I1307K polymorphism is a significant risk factor for CRC in average risk Ashkenazi Jews","volume":"49","author":"Boursi","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0085","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/cncr.10529","article-title":"Clinical and screening implications of the I1307K adenomatous polyposis coli gene variant in Israeli Ashkenazi Jews with familial colorectal neoplasia. Evidence for a founder effect","volume":"94","author":"Rozen","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0090","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0095","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s00268-009-9983-8","article-title":"Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value","volume":"33","author":"Waldmann","year":"2009","journal-title":"World J. Surg."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0100","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0105","first-page":"1","article-title":"Inherited mutations in women with ovarian carcinoma","author":"Norquist","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0110","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1158\/1055-9965.EPI-08-0010","article-title":"CDKN2A\/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families","volume":"17","author":"Aspinwall","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0115","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Castera","year":"2014","journal-title":"EJHG."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0120","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment","volume":"32","author":"Kurian","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0125","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients","volume":"16","author":"LaDuca","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0130","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2014.176","article-title":"Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer","volume":"17","author":"Maxwell","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","article-title":"A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients","volume":"17","author":"Lincoln","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0140","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment","volume":"1","author":"Desmond","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.GIM.0000151155.36470.FF","article-title":"Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications","volume":"7","author":"McClain","year":"2005","journal-title":"Genet. Med."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0155","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.1415979111","article-title":"Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2","volume":"111","author":"Gabai-Kapara","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0160","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jama.2014.12483","article-title":"Population-based screening for BRCA1 and BRCA2: 2014 Lasker award","volume":"312","author":"King","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2017.04.009_bb0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jnci\/dju379","article-title":"Population testing for cancer predisposing BRCA1\/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial","volume":"107","author":"Manchanda","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2017.04.009_bb0170","series-title":"Hereditary Cancer Testing for Patients of Ashkenazi Jewish Ancestry in the Era of Panel Testing","author":"Rinsky","year":"2015"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817307904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817307904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T11:42:54Z","timestamp":1575632574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817307904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0090825817307904"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.04.009","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}